Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ranabir Bhattacharya"'
Autor:
Debdulal Chakraborty, Ashish Sharma, Soumen Mondal, Jay Sheth, Tushar Kanti Sinha, Subhendu Boral, Angshuman Mukherjee, Ranabir Bhattacharya, Ritobroto Maitra
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 36, Iss , Pp 102152- (2024)
Purpose: To compare the safety and efficacy of aflibercept with brolucizumab for recalcitrant diabetic macular edema (DME). Observations: At week 52, no significant visual improvement was noted in the eyes treated with either brolucizumab (P = 0.527)
Externí odkaz:
https://doaj.org/article/b4091cd6f88a49f09fbd50db2271c7b6
Autor:
Debdulal Chakraborty, Soumen Mondal, Subhendu Boral, Arnab Das, Tushar Kanti Sinha, Saptorshi Majumdar, Ranabir Bhattacharya, Ritobroto Maitra
Publikováno v:
Clinical Ophthalmology. 17:1067-1076
Debdulal Chakraborty,1 Soumen Mondal,1 Subhendu Boral,1 Arnab Das,1 Tushar Kanti Sinha,1 Saptorshi Majumdar,1 Ranabir Bhattacharya,2 Ritobroto Maitra3 1Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India; 2Departmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c34d7444c4d5beee6f52ab90a449245
https://doi.org/10.2147/opth.s407219
https://doi.org/10.2147/opth.s407219
Autor:
Debdulal Chakraborty, Sabyasachi Sengupta, Soumen Mondal, Subhendu Boral, Arnab Das, Tushar Kanti Sinha, Ranabir Bhattacharya, Ritobroto Maitra
Publikováno v:
Ophthalmology and Therapy. 11:629-638
To compare the efficacy of innovator ranibizumab (iRBZ-Accentrix, Novartis, India) vs. biosimilar ranibizumab (bRBZ, Razumab-Intas, India) in eyes with diabetic macular edema (DME) in an Indian population.Data of patients with DME who underwent at le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::652f122c3055669ac713637f4c3a721f
https://doi.org/10.1007/s40123-022-00463-5
https://doi.org/10.1007/s40123-022-00463-5